AETNA INC NEW (AET) Stock News
NYSE:AET - New York Stock Exchange, Inc. - US00817Y1082
AET Latest News, Press Relases and Analysis
Here’s Why CVS Health Corp. (CVS) Traded Higher in Q1
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The Hotchkis & Wiley Mid-Cap Value Fund returned -5.63% in the first quarter, underperforming the Russell Midcap Value Index’s -2.11% return. US mid-cap stocks surged post-Presidential […]
Mentions: CVS
UnitedHealth Stock Plunges Over 8% In After-Hours Trading As DOJ Criminal Probe Adds To Turmoil After CEO Shake-Up
The crisis at UnitedHealth Group Inc. (NYSE: UNH) continues to deepen, with a new criminal investigation by federal authorities, following the abrupt departure of its CEO, and a steep decline in stock prices.
Mentions: UNH
Health Insurance Providers Stocks Q1 Highlights: Molina Healthcare (NYSE:MOH)
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Molina Healthcare (NYSE:MOH) and its peers.
2 S&P 500 Stocks to Consider Right Now and 1 to Approach with Caution
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Humana, Elevance, Aetna Face DOJ Lawsuit Over Illegal Kickback Scheme, Discrimination Against Disabled People
The lawsuit alleges that from 2016 through at least 2021, the insurers paid hundreds of millions of dollars in illegal kickbacks to brokers.
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter
Favorable regulatory moves for a new drug application, blowout earnings and promising preclinical data triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.
Nearly 1 million Americans face losing health insurance as Aetna exits ACA marketplace - UPI.com
Nearly a million people in 17 states face losing healthcare coverage after Aetna's parent company announced it would leave the federal insurance marketplace, created under the Affordable Care Act.
What is CVS? 'We are ... working through that very question'
CVS Health is working to balance all parts of its vertically integrated business under new leadership. CEO David Joyner tells Yahoo Finance he's working to define the company.
US Claims Medicare Insurers, Brokers Used Illegal Kickbacks
(Bloomberg) -- The US sued top health insurance companies and brokers, alleging they used illegal kickbacks to steer members into certain private Medicare Advantage plans.Most Read from BloombergNJ Transit Urges Commuters to Work Remotely If Union StrikesNYC Lost $9 Billion of Income to Miami, Palm Beach in Five YearsNew York City Transit System Chips Away at Subway Fare EvasionNYC’s Congestion Toll Raised $159 Million in the First QuarterNYC’s MTA to Cut Costs Instead of Borrowing More to Fund
US accuses health insurers, brokers of Medicare Advantage kickback scheme
BOSTON (Reuters) -The U.S. Department of Justice accused three of the nation's largest health insurers of paying hundreds of millions of dollars in kickbacks to brokers in exchange for steering patients into the insurers' Medicare Advantage plans. In a complaint filed in Boston federal court on Thursday, the Justice Department alleged that CVS Health's Aetna, Elevance Health and Humana engaged in a vast kickback scheme with insurance brokers eHealth, GoHealth and SelectQuote from 2016 to 2021.
Stock Movers: McDonalds, Qualcomm Fall, CVS & Nvidia Up
McDonalds (MCD) is down on reports that US sales fell 3.6% in the first quarter, mainly due to a decline in guest counts. It is the biggest drop in the chain's home market since 2020. CVS is up on news that the company's drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its members. Qualcomm (QCOM) fell after the company's revenue forecast came in below estimates. The company's outlook has renewed fears about the impact of tariffs on the smartphone market, which is Qualcomm's largest market. Nvidia (NVDA) is up after CEO Jensen Huang urged President Trump to change regulations for exporting artificial intelligence technology from the US to the rest of the world. (Source: Bloomberg)
CVS posts Q1 earnings beat, raises full-year guidance
CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare Advantage headwinds.
CVS Reports Upbeat Q1 Earnings, Raises Full-Year Profit Guidance: Retail’s In Wait-And-Watch Mode
The company now expects full-year adjusted EPS in the range of $6.00 to $6.20, up from its previous guidance of $5.75 to $6.00.
CVS raises profit forecast, to exit Obamacare market as turnaround gains steam
(Reuters) -CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health insurance plans in 2026, as it seeks to turn around its fortunes after a series of challenges last year. CVS shares jumped 5% to $69.84 after it raised its 2025 profit forecast to $6 to $6.20 per share from $5.75 to $6 previously. CEO David Joyner, who took the helm of the healthcare conglomerate in October, has laid out cost-cutting plans and reshuffled the top management to help the company navigate one of the most challenging periods in its six-decade history.
CVS tops estimates, hikes guidance as insurance business shows some improvement
The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per share.
CVS’ Aetna to Stop Offering Affordable Care Act Health Plans
CVS Health Corp.’s Aetna unit will exit the Affordable Care Act insurance market in 2026, the company said after reporting better-than-expected first-quarter earnings. The decision follows price hikes on its money-losing plans, which currently cover about 1 million Americans.
Mentions: CVS
A Special Live Debate | Trump's First 100 Days: The Economic Agenda
Bloomberg in partnership with Open to Debate hosts a discussion taking a close look at President Trump's economic agenda after the first 100 days of his second term. Can tariffs be part of a winning US strategy? Is deregulation good for growth? And could the president's medicine mean a recession? Moderator: Mishal Husain, Editor-at-Large, Bloomberg Weekend Panelists: Jeff Ferry, Chief Economist Emeritus, Coalition for a Prosperous America Jason Furman, Aetna Professor of the Practice of Economic Policy, Harvard University Mariana Mazzucato, Professor of Economics, University College London & Author of Mission Economy Stephen Moore, Co-Founder, Unleash Prosperity & Fellow, Heritage Foundation Allison Schrager, Columnist, Bloomberg Opinion (Source: Bloomberg)
Today's NYT Mini Crossword Answers for Sunday, April 27
Here's today's NYT Mini Crossword answer. These answers will help you solve New York Times' popular crossword game, Mini Crossword, every day!
Jim Cramer Backs CVS Health Corporation (CVS): “Crushing It—Only Drugstore Left Standing with Aetna in Its Corner”
We recently published a list of Jim Cramer Defended American Superiority and Discussed These 13 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role […]
Shares of CVS and Dollar General made a turnaround due to their 'newfound sole survivor status,' Jim Cramer says
CNBC's Jim Cramer on Tuesday suggested why CVS and Dollar General have seen gains recently after lagging last year.
2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs
Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.
Macro Headwind-Immune CVS Health Stock Set to Extend 50% YTD Rally
CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked off Trump-mania, tariff levies, and a global trade war like water off a duck’s back. The stock is up 3% over the past five days and up 42% since January — wholly opposed to the market squall enveloping the world’s major stock indices and shaving trillions from index valuations, in recent days. Most recognizable for its corner drugstores, CVS’ transformative acquisition of
Top 3 S&P 500 Winners in a Losing Market
Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.
S&P 500 Gains and Losses Today: Index Reverses Early Gains Amid Tariff Worries
The S&P 500 fell 1.6% on Tuesday, April 8, 2025, as investors braced for new tariffs to take effect.
Humana and CVS stock pop on Medicare payout and Dr. Oz news
Health insurance stocks extended Monday’s gains into Tuesday after Medicare regulators finalized stronger-than-expected 2026 payment rates.
Top Stock Movers Now: CVS, Nvidia, RPM International, and More
Stocks surged at midday Tuesday, with the Dow Jones Industrial Average jumping nearly 1,000 points, as the major indexes rebounded somewhat from tariff-induced losses.
Humana and Other Health Insurance Stocks Surge on Higher-Than-Expected Medicare Payments
Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers than previously estimated.
CVS Stock Pops as Pharmacy Chain Improves Full-Year Outlook, Taps New Execs
CVS shares jumped Tuesday after the company improved its full-year outlook and named a new chief financial officer.
ClearBridge Dividend Strategy Added TE Connectivity plc (TEL) on Dip
ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The ClearBridge Dividend Strategy proved resilient and delivered positive returns despite a 4.3% decline in the benchmark S&P 500 Index. Despite increased caution over the economy and markets, the firm […]
Mentions: TEL
Here’s Why ClearBridge Dividend Strategy is Expecting Considerable Revenue Growth From CVS Health Corporation (CVS)
ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The ClearBridge Dividend Strategy proved resilient and delivered positive returns despite a 4.3% decline in the benchmark S&P 500 Index. Despite increased caution over the economy and markets, the firm […]
Mentions: CVS